Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FB4SL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,840
Award facts
- Contract value 100% obligated
- $13,840.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,840.04 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This delivery order represents a routine pharmaceutical procurement through DLA's extensive network for medical supply chain support, which serves military healthcare systems, the Defense Health Agency, and other federal health programs. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition, combined with its established indefinite delivery contract framework, enables efficient fulfillment of individual medication orders such as this one for Xifaxan, an antibiotic used to treat traveler's diarrhea and hepatic encephalopathy. The transaction exemplifies the vendor's role as a key supplier within the Defense Logistics Agency's pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DR26FB4SL?
SPE2DR26FB4SL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FB4SL worth?
The government has obligated $13,840 on SPE2DR26FB4SL.
Is contract SPE2DR26FB4SL an order under another contract?
Yes. SPE2DR26FB4SL is a delivery order under SPE2DR25D2208, an indefinite delivery contract.
Was contract SPE2DR26FB4SL competed?
The extent of competition for SPE2DR26FB4SL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award